Fritz Gerber, who led Roche for 2 decades, dies; ADC Therapeutics tries again for an IPO, sets terms
→ Fritz Gerber, the 92-year-old ex-Roche CEO who steered the company to a majority stake in Genentech, has died. Gerber was CEO from 1978 to 1998, and chairman for a few years after that. The company credits him with taking a leading role in acquiring a majority stake in Genentech, a foundational move that led to the full buyout 11 years ago. Deals to acquire PCR technology and the takeover of Boehringer Mannheim also set up a big play in diagnostics, where Roche is a world leader today.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.